Clinical Trials Directory

Trials / Completed

CompletedNCT01575639

Prednisolone in Infantile Spasms- High Dose Versus Usual Dose

Randomized Trial of High Dose (4mg/kg) Versus Usual Dose (2mg/kg) Oral Prednisolone in the Treatment of Infantile Spasms.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Lady Hardinge Medical College · Other Government
Sex
All
Age
3 Months – 24 Months
Healthy volunteers
Not accepted

Summary

Infantile spasms comprise a difficult to treat type of epilepsy in young children. Hormonal treatment, i.e. Prednisolone and ACTH are considered the treatment of choice. There is no consensus on the dosage of Prednisolone required for the treatment of infantile spasms. Recent data has shown that a high dose (4 mg/kg/day) may be more efficacious than the usual dose (2 mg/kg/day). However, there are no randomized controlled trials comparing these doses. A higher steroid dose may also be associated with more side effects. Therefore, this study was planned to compare the efficacy and tolerability of the high dose versus the usual dose in children with infantile spasms, in a randomized open-label trial design

Conditions

Interventions

TypeNameDescription
DRUGOral prednisoloneDose will be different in the two groups. the high dose group will receive 4 mg/kg/day. The usual dose group will receive 2 mg/kg/day

Timeline

Start date
2012-02-01
Primary completion
2013-02-01
Completion
2013-03-01
First posted
2012-04-11
Last updated
2013-04-09

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01575639. Inclusion in this directory is not an endorsement.